Actively Recruiting
Mindfulness Walking Intervention to Enhance Resilience (iWalk)
Led by University of Illinois at Urbana-Champaign · Updated on 2025-12-16
90
Participants Needed
1
Research Sites
239 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS). The objectives are to evaluate: 1. Recruitment capability and retention rates, 2. Acceptability and adherence to the intervention, 3. Feasibility of assessment procedures, and 4. Preliminary effects on psychological, physiological, and behavioral outcomes.
CONDITIONS
Official Title
Mindfulness Walking Intervention to Enhance Resilience (iWalk)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.
- No regular meditation practice (e.g., at least 10 minutes per day) and no attendance at meditation classes or community programs
- No previous meditation training via coaching, certification, or life coaching
- Have internet access
- No severe cognitive impairment as indicated by a score of 21 or higher on the Modified Telephonic Interview for Cognitive Status (TICS-M)
- Able to walk with or without an assistive device (Patient determined Disease Steps score from 0 to 6)
- Willing to be randomized to an intervention or control group
- Willing to wear a Fitbit wrist smart watch for eight weeks
- Right-handed according to the Edinburgh Handedness Questionnaire
- Willing to participate in all assessments including in-person EEG and cognitive testing, online surveys/questionnaires, and interviews or focus groups
- Willing to wear a Hexoskin t-shirt heart rate variability monitor during in-person assessments
You will not qualify if you...
- Inability to speak, read, write, or listen in English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Illinois Urbana-Champaign
Urbana, Illinois, United States, 61801
Actively Recruiting
Research Team
C
Chung-Yi Chiu
CONTACT
V
Vaishnavi Sridharan
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here